Markets.com Logo

VIR

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.3172$
  • Previous Close
    4.4219$
  • 52 Week Change
    10.30$
  • Day Range
    -0.10$
  • 52 Week High/Low
    4.155$ - 14.45$
  • Dividend Per Share
    --
  • Market cap
    608 M$
  • EPS
    -0.8
  • Beta
    1.184
  • Volume
    --

About

VIR.US refers to the common stock of Vir Biotechnology, Inc. traded on the NASDAQ stock exchange. Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The ".US" suffix simply indicates that the stock is traded on a United States stock exchange.
AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

AVGO stock dropped 11% today: Why is Broadcom Inc stock going down?

Frances Wang|--
RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

RGTI stock is dropping: Where will Rigetti Computing be in 5 years?

Frances Wang|--
Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Gold Price Forecast: XAU/USD above $4,300, will gold price continue to rise?

Frances Wang|--
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--

Factors

Virology Stocks (VIR.US) Price Factors: Company Performance: Positive clinical trial results, regulatory approvals, and successful product launches drive the price up; conversely, failures or delays lead to price declines. Market Sentiment: Overall investor confidence in the biotechnology sector or concerns about specific viruses or diseases influence demand and, therefore, the stock price. Regulatory Environment: Changes in regulations affecting drug development, approval processes, or pricing policies impact the profitability and attractiveness of virology companies. Competition: The emergence of competing therapies or technologies affects the market share and future revenue potential of virology companies, influencing investor perception and stock value. Pandemic/Epidemic Outbreaks: The outbreak or escalation of viral diseases often increases demand for virology stocks, as investors anticipate increased sales of vaccines, treatments, and diagnostic tools.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

What does CFD mean in trading: How to start CFD Trading in 2026?

What does CFD mean in trading: How to start CFD Trading in 2026?

Ghko B|--
A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--